Innovation Improves Care Delivery Around the World

AllscriptsAllscripts Healthcare Solutions (NASDAQ: MDRX) was recently awarded five separate patents over the course of just eight days, reflecting the company's commitment to delivering unique solutions to its clients and demonstrating its significant momentum in health IT innovation. The Allscripts patent program is expected to add numerous additional patents throughout the remainder of 2020 as the company will deliver innovation to improve how clinicians deliver care and connect the overall patient experience.

Each of the patents recently awarded contributes to streamlining and improving healthcare delivery. For example, one of the patents is for an application that connects electronic health records (EHRs) to various wellness applications to provide patients frictionless goal-tacking functionality, which directly leads to a higher level of patient engagement. Another application enables API calls from EHRs to initiate searches over genetic testing data stores. A patent was also issued for an application that helps organizations secure data in a HIPAA-compliant manner that will not cause performance issues that are often associated with typical encryption practices.

With a long history as a leader in healthcare technology, Allscripts continues seizing opportunities to enrich its offerings. Through extensive investment in software R&D these efforts have resulted in an extensive patent program that has 150 patents issued plus another 150-plus patents currently pending. In 2013 there was one patent in the Allscripts portfolio. Allscripts’ vision remains firmly set on providing healthcare organizations the distinctive solutions they need to deliver excellent care.

"Innovation is at the core of everything we do and I’m proud of the visionary work our team consistently executes upon to grow the capabilities of our solutions to help our clients deliver better care," said Allscripts CEO, Paul Black. "Allscripts believes that healthcare solutions should be open, for everyone, and leading-edge innovation is the driver to make that a reality."

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Most Popular Now

Open Call HORIZON-JU-IHI-2022-03-05: Dig…

Mental health disorders represent an area of severe unmet public health need. This has been further negatively impacted by the COVID-19 pandemic, with a substantial increase in the number and...

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Brain Area Necessary for Fluid Intellige…

A team led by UCL and UCLH researchers have mapped the parts of the brain that support our ability to solve problems without prior experience - otherwise known as fluid...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...